Fourth, regarding overall survival, patients with NRG1 fusions, especially those with mucinous lung adenocarcinoma, have been shown to have reduced survival times compared to those without NRG1 fusions (62). This evidence concerns the gene NRG1 and lung colloid adenocarcinoma.